Transient, Unexplained, and Psychogenic Visual Loss in Children

  • Michael C. Brodsky
Chapter

Abstract

Some children have visual disturbances that occur in the absence of, or are out of proportion to, their objective ophthalmological findings. These symptoms reflect a wide range of processes that may be benign or a sign of neurological, systemic, or psychiatric disease. This chapter deals with the neuro-ophthalmologic detection of organic and psychogenic disorders that may manifest as transient or unexplained visual loss of the same episodic visual disturbances that occur in childhood, but several formidable problems confront the physician who is trying to reach the correct diagnosis. The descriptions of episodic visual disturbances and hallucinations in children are less complex in detail than those of the adult population because children have limited vocabulary and limited experiential basis of sensory phenomenon to draw upon.

References

  1. 1.
    Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry. 1983;40:884–889.PubMedGoogle Scholar
  2. 2.
    Abu-Arafeh I, Callaghan M. Short migraine attacks of less than 2 h duration in children and adolescents. Cephalalgia. 2004;24:333–338.PubMedGoogle Scholar
  3. 3.
    Abu-Arafeh I, Russell G. Prevalence and causes of headache in schoolchildren. Br Med J. 1994;309:765–769.Google Scholar
  4. 4.
    Afridi S, Giffin NJ, Kaube H, et al. A positron emission tomo­graphy study in spontaneous migraine. Arch Neurol. 2005;62:1270–1275.PubMedGoogle Scholar
  5. 5.
    Afridi S, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005;128:932–939.PubMedGoogle Scholar
  6. 6.
    Aicardi J. Diseases of Nervous System in Childhood. 2nd ed. London: Mackeith Press; 1998.Google Scholar
  7. 7.
    Aicardi J, Bourgeois M, Goutieres F. Alternating hemiplegia of childhood: clinical findings and diagnostic criteria. In: Andermann F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995:3–18.Google Scholar
  8. 8.
    Akin R, Unay B, Sarici SU, et al. Evaluation of visual evoked potentials in children with headache. Turk J Pediatr. 2005;47:150–152.PubMedGoogle Scholar
  9. 9.
    Aldrich MS, Vanderzant CW, Alessi AG, et al. Tidal ictal cortical blindness with permanent visual loss. Epilepsy. 1989;30:116–120.Google Scholar
  10. 10.
    Alvarez WC. The migrainous scotoma as studied in 618 persons. Am J Ophthalmol. 1960;49:489–504.PubMedGoogle Scholar
  11. 11.
    American Council on Headache Education with Lynne M. Constantine and Suzanne Scott. Migraine: The Complete Guide: A Comprehensive Resource Book for People with Migraine, their Families, and Physicians. New York: Dell Publishing; 1994:51.Google Scholar
  12. 12.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. (rev). Washington, DC: American Psychiatric Association; 1987Google Scholar
  13. 13.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association: Washington, DC; 1994.Google Scholar
  14. 14.
    Amery WK, Waelkens J, Vandenbergh V. The sensorium of the migraineur. Ital J Neurol Sci. 1988;9:539–545.PubMedGoogle Scholar
  15. 15.
    Andersson KE, Vinge E. Beta-adrenoreceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs. 1990;39:355–373.PubMedGoogle Scholar
  16. 16.
    Appleton R, Farrell K, Buncic JR. Amaurosis fugax in teenagers: a migrainous variant. Am J Dis Child. 1988;142:331–333.PubMedGoogle Scholar
  17. 17.
    Arffa RC. Grayson’s Diseases of the Cornea. 3rd ed. St Louis, MO: C.V. Mosby; 1991:401–416.Google Scholar
  18. 18.
    Artman M, Grayson M, Boerth RC. Propranolol in children: safety-toxicity. Pediatrics. 1982;70:30–31.PubMedGoogle Scholar
  19. 19.
    Aschwanden C. Experts question placebo pill for children. New York Times; May 27, 2008;D5, D7Google Scholar
  20. 20.
    Ashkenazi S, Bellah G, Cleary TG. Hallucinations as an initial manifestation of shigellosis. J Pediatr. 1989;114:95–96.PubMedGoogle Scholar
  21. 21.
    Bahn CA. The psychoneurotic factor in ophthalmic practice. Am J Ophthalmol. 1943;26:369–378.Google Scholar
  22. 22.
    Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet. 2001;357:1016–1017.PubMedGoogle Scholar
  23. 23.
    Bain KE, Beatty S, Lloyd C. Non-organic visual loss in children. J AAPOS. 2001;5:131–132.Google Scholar
  24. 24.
    Barabas G, Matthews WS, Ferrari M. Childhood migraine and motion sickness. Pediatrics. 1983;72:188–190.PubMedGoogle Scholar
  25. 25.
    Barlow CF. Headaches and Migraine in Childhood. London: Spastics International Pubs; 1984.Google Scholar
  26. 26.
    Barlow CF. Migraine in the infant and toddler. J Child Neurol. 1994;9:92–94.PubMedGoogle Scholar
  27. 27.
    Basser LS. Benign paroxysmal vertigo of childhood (a variant of vestibular neuronitis). Brain. 1964;87:141–152.PubMedGoogle Scholar
  28. 28.
    Basser LS. The relation of migraine and epilepsy. Brain. 1969;92:258–300.Google Scholar
  29. 29.
    Bender MB, Feldman M, Sobin AJ. Palinopsia. Brain. 1968;91:321–338.PubMedGoogle Scholar
  30. 29a.
    Benedik MP, Zaletel M, Meglic NP, et al. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Catheter Cardiovasc Interv. 2007;70:999–1007.PubMedGoogle Scholar
  31. 30.
    Berman RJ. Psychogenic visual disorders in an abused child: a case report. Am J Optom Physiol Opt. 1978;55:735–738.PubMedGoogle Scholar
  32. 31.
    Bernard GA, Bennett JL. Vasospastic amaurosis fugax. Arch Ophthalmol. 1999;117:1568–1569.PubMedGoogle Scholar
  33. 32.
    Besch D, Kurtenbach A, Apfelstedt-Sylla E, et al. Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol. 2002;104:151–170.PubMedGoogle Scholar
  34. 33.
    Bickerstaff ER. Impairment of consciousness in migraine. Lancet. 1961;2:1057–1059.PubMedGoogle Scholar
  35. 34.
    Bien CG, Benninger FO, Urbach H, et al. Localizing value to epileptic auras. Brain. 2000;123:244–253.PubMedGoogle Scholar
  36. 35.
    Bigley GK, Sharp FR. Reversible alexia without agraphia due to migraine. Arch Neurol. 1983;40:114–115.PubMedGoogle Scholar
  37. 36.
    Bille B. Migraine in school children. Acta Paediatr Scand. 1962;51(Suppl 36):1–151.Google Scholar
  38. 37.
    Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache. 1977;17:61–63.PubMedGoogle Scholar
  39. 38.
    Biller J, Johnson MR, Adams HP, et al. Further observations on cerebral or retinal ischemia in patients with right-to-left intracardiac shunts. Arch Neurol. 1987;44:740.PubMedGoogle Scholar
  40. 39.
    Birnbach CD, Jarvelainen M, Possin DE, et al. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994;101:1211–1219.PubMedGoogle Scholar
  41. 40.
    Bourke RD, Gole GA. Detection of functional vision loss using the Ishihara plates. Aust N Z J Ophthalmol. 1994;22:116–118.Google Scholar
  42. 41.
    Brandt T. A chameleon among the episodic vertigo syndromes: “migrainous vertigo” or “vestibular migraine”. Cephalalgia. 2004;24:81–82.PubMedGoogle Scholar
  43. 42.
    Brodsky MC. Contractile morning glory disc causing transient monocular blindness in a child. Arch Ophthalmol. 2006;124:1199–1201.PubMedGoogle Scholar
  44. 43.
    Brust JC, Behrens MM. “Release hallucinations” as the major symptom of posterior cerebral artery occlusion: a report of 2 cases. Ann Neurol. 1977;2:432–436.PubMedGoogle Scholar
  45. 44.
    Burch EP. Psychoneurotic reaction patterns in ophthalmology. Trans Am Ophthalmol Soc. 1950;48:370–394.PubMedGoogle Scholar
  46. 45.
    Burger SK, Saul RF, Selhorst JB, et al. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991;325:870–873.PubMedGoogle Scholar
  47. 46.
    Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123:1703–1709.PubMedGoogle Scholar
  48. 47.
    Byrd RL, Rohrbaugh TM, Raney RB Jr, et al. Transient cortical blindness secondary to vincristine therapy in childhood malignancies. Cancer. 1981;47:37–40.PubMedGoogle Scholar
  49. 48.
    Callanan D, Gass DM. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot syndrome and acute idiopathic blind spot enlargement. Ophthalmology. 1992;99:1678–1685.PubMedGoogle Scholar
  50. 49.
    Campbell JK. Manifestations of migraine. Neurol Clin. 1990;8:841–855.PubMedGoogle Scholar
  51. 50.
    Caplan LR. Top of the basilar syndrome. Neurology. 1980;30:72–79.PubMedGoogle Scholar
  52. 51.
    Caraballo RH, Cersósimo RO, Fejerman N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia. 2008;49:288–297.PubMedGoogle Scholar
  53. 52.
    Caraballo R, Cersósimo R, Fejerman N. Panayiotopoulos syndrome: a prospective study of 192 patients. Epilepsia. 2007;48:1054–1061.PubMedGoogle Scholar
  54. 53.
    Carlow TJ. Oculomotor ophthalmoplegic migraine: is it really migraine? J Neuroophthalmol. 2002;22:215–221.PubMedGoogle Scholar
  55. 54.
    Carlsson A, Forsgren L, Nylander P-O, et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2–21.1. Neurology. 2002;59:1804–1807.PubMedGoogle Scholar
  56. 55.
    Catalano RA, Simon JW, Krohel GB, et al. Functional visual loss in children. Ophthalmology. 1986;93:385–390.Google Scholar
  57. 56.
    Chen CS, Lee AW, Karagiannis A, et al. Practical applications to functional visual loss. J Clin Neurosci. 2007;14:1–7.PubMedGoogle Scholar
  58. 57.
    Chou YH, Wang PJ, Lin MY, et al. Acute hemiplegia in infancy and childhood. Acta Pediatr Sin. 1994;35:45–56.Google Scholar
  59. 58.
    Chu ML, Shinnar S. Headaches in children under 7 years of age. Arch Neurol. 1992;49:79–82.PubMedGoogle Scholar
  60. 59.
    Chun HG, Leyland-Jones BR, Caryk SM, et al. Central nervous system toxicity of fludarabine phosphate. Cancer Treat Res. 1986;70:1225–1228.Google Scholar
  61. 60.
    Cogan DJ. Visual hallucinations as release phenomena. Graefes Arch Clin Exp Ophthalmol. 1973;188:139–150.Google Scholar
  62. 61.
    Cohn R. Phantom vision. Arch Neurol (Chic). 1971;25:468.Google Scholar
  63. 62.
    Cologno D, Torelli P, Manzoni GC. Transient visual disturbances during migraine without aura attacks. Headache. 2002;42:930–933.PubMedGoogle Scholar
  64. 63.
    Congdon PJ, Forsythe WI. Migraine in childhood: a study of 300 children. Dev Med Child Neurol. 1979;21:209–216.Google Scholar
  65. 64.
    Copperman SM. “Alice in Wonderland” syndrome as a presenting symptom of infectious mononucleosis in children: a description of three affected young people. Clin Pediatr. 1977;16:143–146.Google Scholar
  66. 65.
    Corbett JJ. Neuroophthalmic complications of migraine and cluster headaches. Neurol Clin. 1983;4:973–995.Google Scholar
  67. 66.
    Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979;36:695–699.PubMedGoogle Scholar
  68. 67.
    Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118:e1237-e1243.PubMedGoogle Scholar
  69. 68.
    Crevits L, Bosman T. Migraine-related vertigo: towards a distinctive entity. Clin Neurol Neurosurg. 2005;107:82–87.PubMedGoogle Scholar
  70. 69.
    Critchley M. Types of visual perseveration: “palinopsia” and “illusory visual spread”. Brain. 1951;74:267–299.PubMedGoogle Scholar
  71. 70.
    Cutrer FM. Migraine: does one size fit all? Curr Opin Neurol. 2003;16:315–317.PubMedGoogle Scholar
  72. 71.
    Cutrer FM, Huerter K. Migraine aura. Neurology. 2007;13:118–125.Google Scholar
  73. 72.
    Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2006;26:171–180.PubMedGoogle Scholar
  74. 73.
    Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998;43:25–31.PubMedGoogle Scholar
  75. 74.
    D’Andrea G, Toldo M, Cortelazzo S, et al. Platelet activity in migraine. Headache. 1982;22:207–212.PubMedGoogle Scholar
  76. 75.
    Daroff RB. Retinal migraine. J Neuroophthalmol. 2007;27:83.PubMedGoogle Scholar
  77. 76.
    Davis FA, Bergen D, Schauf C, et al. Movement phosphenes in optic neuritis: a new clinical sign. Neurology. 1976;26:1100–1104.PubMedGoogle Scholar
  78. 77.
    Deonna T, Ziegler A, Despland PA. Paroxysmal visual disturbances of epileptic origin and occipital epilepsy in children. J Neuroopediatrics. 1984;15:131–135.Google Scholar
  79. 78.
    Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246:883–892.PubMedGoogle Scholar
  80. 79.
    Digre KB, Durcan FJ, Branch DW, et al. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol. 1989;25:228–232.PubMedGoogle Scholar
  81. 80.
    Digre KB. Light sensitivity in migraineurs. Headache. 2003;43:917–920.PubMedGoogle Scholar
  82. 81.
    Dobrovolny R, Liskova P, Ledvinova J, et al. Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation. Am J Ophthalmol. 2007;143:663–671.PubMedGoogle Scholar
  83. 82.
    Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747–750.PubMedGoogle Scholar
  84. 83.
    Doyle E, Vote BJ, Casswell AG. Retinal migraine: caught in the act. Br J Ophthalmol. 2004;88:286–290.Google Scholar
  85. 84.
    Drexel M, Harnoncourt K, Meyer J. Transesophageal two-dimensional echocardiography in young patients with cerebral ischemic events. Stroke. 1988;19:345.Google Scholar
  86. 85.
    Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465–469.PubMedGoogle Scholar
  87. 86.
    Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalagia. 2002;22:117–124.Google Scholar
  88. 87.
    Drummond PD. Photophobia and autonomic responses to facial pain in migraine. Brain. 1997;120:1857–1864.PubMedGoogle Scholar
  89. 88.
    Drummond PD, Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia. 1993;13:321–323.PubMedGoogle Scholar
  90. 89.
    Duckro PN, Cantwell-Simmons EL. A review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache. 1989;29:428–433.PubMedGoogle Scholar
  91. 90.
    Ducros A, Joutel A, Vahedi K, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 1997;42:885–890.PubMedGoogle Scholar
  92. 91.
    Dunn DW, Weissberg LA. Peduncular hallucinosis caused by brainstem compression. Neurology. 1983;33:1360–1361.PubMedGoogle Scholar
  93. 92.
    Durkan GP, Troost BT, Slamovits TL. Recurrent painless oculomotor palsy in children. A variant of ophthalmoplegic migraine? Headache. 1981;21:58–62.PubMedGoogle Scholar
  94. 93.
    Dutton GN, McKillop EC, Saidkasimova S. Visual problems as a result of brain damage in children. Br J Ophthalmol. 2006;90:932–933.PubMedGoogle Scholar
  95. 94.
    Dvorkin G, Andermann F, Melancon D, et al. Malignant migraine syndrome: classical migraine, occipital seizures, and alternating strokes. Neurology. 1984;34:245. Abstract.Google Scholar
  96. 95.
    Eames TA. A study of tubular and spiral central fields in hysteria. Am J Ophthalmol. 1947;30:610–611.PubMedGoogle Scholar
  97. 96.
    Edgell HG, Kolvin I. Childhood hallucinations. J Child Psychol Psychiatry. 1972;13:279–287.Google Scholar
  98. 97.
    Egan RA. Ocular motor features of alternating hemiplegia of childhood. J Neuroophthalmol. 2002;22:99–101.PubMedGoogle Scholar
  99. 98.
    Ehyai AB, Fenichel GM. The natural history of acute confusional migraine. Arch Neurol. 1978;35:368–369.PubMedGoogle Scholar
  100. 99.
    Elliot D, Traboulsi EI, Maumenee IH. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol. 1993;115:360–367.Google Scholar
  101. 100.
    Elser JM, Woody RC. Migraine headache in the infant and young child. Headache. 1990;30:366–368.PubMedGoogle Scholar
  102. 101.
    Emery ES. Acute confusional state in children with migraine. Pediatrics. 1977;60:110–114.Google Scholar
  103. 102.
    Engelsen BA, Tzoulis C, Karlsen B, et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008;131:818–828.PubMedGoogle Scholar
  104. 103.
    Fang W, Huang C-C, Lee C-C, et al. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol. 1993;50:977–980.PubMedGoogle Scholar
  105. 104.
    Feinberg WM, Rapcsak SZ. “Peduncular hallucinosis” following paramedian thalamic infarction. Neurology. 1989;39:1535–1536.PubMedGoogle Scholar
  106. 105.
    Ferreira J, Garcia N, Pedreira L. Topiramate in pediatric and adolescent migraine patients: a retrospective analysis (abstract). Headache. 2002;42:453.Google Scholar
  107. 106.
    Ferrie C, Caraballo R, Covanis A, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol. 2006;48:236–240.PubMedGoogle Scholar
  108. 107.
    Fisher CM, Adams RD. Transient global amnesia. Trans Am Neurol Assoc. 1958;83:143–145.Google Scholar
  109. 108.
    Fisher CM. Late in life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7:9–17.PubMedGoogle Scholar
  110. 109.
    Fishman GA, Farber M, Patel BS, et al. Visual acuity loss in Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–814.PubMedGoogle Scholar
  111. 110.
    Fletcher WA, Imes RK, Goodman D, et al. Acute idiopathic blind spot enlargement. A big blind spot syndrome without optic disc edema. Arch Ophthalmol. 1988;106:44–49.PubMedGoogle Scholar
  112. 111.
    Forsyth WI, Gillies D, Sills M. Propranolol (“Inderal”) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26:737–741.Google Scholar
  113. 112.
    Fusco L, Vigevano F. Alternating hemiplegia of childhood: clinical finding during attacks. In: Anderman F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995:29–41.Google Scholar
  114. 113.
    Gancher ST, Nutt JG. Autosomal dominant episodic ataxia: a heterogenous syndrome. Mov Disord. 1986;1:329–353.Google Scholar
  115. 114.
    Garralda ME. Hallucinations in children with conduct and emotional disorders. I: the clinical phenomena. Psychol Med. 1984;14:589–596.PubMedGoogle Scholar
  116. 115.
    Garralda ME. Hallucinations in children with conduct and emotional disorders. II: the follow-up study. Psychol Med. 1984;14:597–604.PubMedGoogle Scholar
  117. 116.
    Gascon G, Barlow C. Juvenile migraine presenting as an acute confusional state. Pediatrics. 1970;45:628–635.PubMedGoogle Scholar
  118. 117.
    Gascon GG. Chronic and recurrent headaches in children and adolescents. Pediatr Clin North Am. 1984;31:1027–1051.PubMedGoogle Scholar
  119. 118.
    Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, I. 3rd ed. St Louis, MO: CV Mosby; 1987:256–258.Google Scholar
  120. 119.
    Gastaut H. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Dravet CH, Bureau M, eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey; 1992:150–170.Google Scholar
  121. 120.
    Gastaut H. A new type of epilepsy: benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr. 1982;13:13–22.PubMedGoogle Scholar
  122. 121.
    Gastaut H. Clinical Analysis in the Epilepsies: Electroclinical Correlations. Springfield, IL: Charles C. Thomas; 1954:8–44.Google Scholar
  123. 122.
    Gastaut H. A new type of epilepsy: benign. Partial epilepsy of childhood with occipital spike wave. Clin Electroencephalogr. 1982;13:22.Google Scholar
  124. 123.
    Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol. 1987;21:602–604.PubMedGoogle Scholar
  125. 124.
    Gibbs FA, Gibbs EL. Atlas of Electroencephalography, II: Epilepsy. Cambridge, MA: Addison-Wesley Press; 1952:222–224.Google Scholar
  126. 125.
    Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNAIA mutation. Dev Med Child Neurol. 2002;44:490–493.PubMedGoogle Scholar
  127. 126.
    Gittinger JW Jr, Miller NR, Keltner JL, et al. Sugarplum fairies: visual hallucinations. Surv Ophthalmol. 1982;27:42–48.PubMedGoogle Scholar
  128. 127.
    Glista GG, Mellinger JF, Rooke ED. Familial hemiplegic migraine. Mayo Clin Proc. 1975;50:307–311.PubMedGoogle Scholar
  129. 128.
    Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules, and therapeutics. Trends Mol Med. 2007;13:39–44.PubMedGoogle Scholar
  130. 129.
    Goadsby PJ. Sporadic hemiplegic migraine: stamp collecting or food for thought? Neurology. 2008;60:536–537.Google Scholar
  131. 130.
    Goadsby PJ, Duckworth JW. Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol. 1987;253:R270-R274.PubMedGoogle Scholar
  132. 131.
    Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat. 1997;190:367–375.PubMedGoogle Scholar
  133. 132.
    Goadsby PJ, Kullmann DK. Another migraine gene: further opportunities to understand an important disorder. Lancet. 2005;366:345–346.PubMedGoogle Scholar
  134. 133.
    Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med. 2002;346:257–269.PubMedGoogle Scholar
  135. 134.
    Goadsby PJ, Silberstein SD. Headache. In: Asbury A, Marsden CD, eds. Blue Books in Practical Neurology. New York: Butterworth-Heinemann; 1997.Google Scholar
  136. 135.
    Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation if six cases. Compr Psychiatry. 1090;30:90–98.Google Scholar
  137. 136.
    Golden GS. The Alice in Wonderland syndrome in juvenile migraine. Pediatrics. 1979;63:517–519.PubMedGoogle Scholar
  138. 136a.
    Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–3959.PubMedGoogle Scholar
  139. 137.
    Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache. 1991;31:533–536.PubMedGoogle Scholar
  140. 138.
    Goodale M, Milner D. Sight Unseen. Oxford: Oxford University Press; 2005.Google Scholar
  141. 139.
    Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS: a correlative study of the clinical features and mitochondrial DNA mutation). Neurology. 1992;42:545–550.PubMedGoogle Scholar
  142. 140.
    Gowers WR. Cases of cerebral tumor illustrating diagnosis and localization. Lancet. 1879;1:363–365.Google Scholar
  143. 141.
    Graether JM. Transient dilation of one eye with simultaneous dilation of retinal veins. Arch Ophthalmol. 1963;70:342–345.PubMedGoogle Scholar
  144. 142.
    Grant WM. Toxicology of the Eye. Springfield, IL: Charles C. Thomas; 1974:55–56.Google Scholar
  145. 143.
    Greenblatt SH. Post-traumatic cerebral blindness. Association with migraine and seizure diathesis. JAMA. 1973;225:1073–1076.PubMedGoogle Scholar
  146. 144.
    Gross C. The many faces of infectious mononucleosis: the spectrum of Epstein-Barre virus infection in children. Pediatr Rev. 1985;7:35–44.Google Scholar
  147. 145.
    Grüter T, Grüter M. An Underestimated Handicap: Congenital Prosopagnosia. Geneva, Switzerland: EUPO course; 2008:51–53, Sept. 5–7Google Scholar
  148. 146.
    Grüter M, Grüter T, Bell V, et al. Hereditary prosopagnosia: the first case series. Cortex. 2007;43:734–739.Google Scholar
  149. 147.
    Grüter T, Grüter M, Carbon C. Neural and genetic foundations of face recognition and prosopagnosia. J Neuropsychol. 2008;2:79–97.PubMedGoogle Scholar
  150. 148.
    Guggenheim FG. Somatoform disorders. In: Kaplan BJ, Saddock VA. Comprehensive Textbook of Psychiatry, VI. 6th ed.; 1995Google Scholar
  151. 149.
    Guilleminault C, ed. Sleep and Its Disorders in Children. New York: Raven Press; 1987:181–183.Google Scholar
  152. 150.
    Guilleminault C. Narcolepsy. In: Chokroverty S, ed. Sleep Disorders Medicine. Basic Science, Technical Considerations, and Clinical Aspects. Boston: Butterworth Heinemann; 1994:241–243.Google Scholar
  153. 151.
    Haan J, Terwindt GM, Ferrari MD. Genetics of migraine. Adv Headache. 1997;15:43–60.Google Scholar
  154. 152.
    Hachinski VC, Porchawka J, Steele JC. Visual symptomatology of the migraine syndrome. Neurology. 1973;23:570–579.PubMedGoogle Scholar
  155. 153.
    Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 2001;98:4687–4692.PubMedGoogle Scholar
  156. 154.
    Hakkarainen J, Quiding H, Stockman O. Mild analgesics as an alternative to ergotamine in migraine: a comparative trial with acetylsalicylic acid, ergotamine tartrate, and dextro-propoxyphene compound. J Clin Pharmacol. 1980;20:590–595.PubMedGoogle Scholar
  157. 155.
    Hamalainen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology. 1997;48:103–107.PubMedGoogle Scholar
  158. 156.
    Hamed LM, Glaser JS, Gass JD, et al. Protracted enlargement of the blind spot in multiple evanescent white dot syndrome. Arch Ophthalmol. 1989;107:194–198.PubMedGoogle Scholar
  159. 157.
    Hanington E. Migraine: a blood disorder? Lancet. 1978;1:501–502.Google Scholar
  160. 158.
    Hanson RR. Headaches in childhood. Semin Neurol. 1988;8:51–60.PubMedGoogle Scholar
  161. 159.
    Harding GF, Wild JM, Robertson KA, et al. Electrooculography, electroretinography, visual-evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia. 2000;41:420–431.Google Scholar
  162. 160.
    Harris W. Hemianopsia with special reference to its transient varieties. Brain. 1897;20:308–364.Google Scholar
  163. 161.
    Hartong DT, Pott J-W, Kooijman AC. Six patients with bradyopsia (slow vision): clinical features and course of the disease. Ophthalmology. 2007;114:2323–2331.PubMedGoogle Scholar
  164. 162.
    Hauser RA, Lacey M, Knight R. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45:1078–1083.PubMedGoogle Scholar
  165. 163.
    Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia. 2004;24:1–160.Google Scholar
  166. 164.
    Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache. 1989;29:507–509.PubMedGoogle Scholar
  167. 165.
    Hicks PA, Leavitt JA, Mokris B. Ophthalmic manifestations of vertebral artery dissection: patients seen at the Mayo Clinic from 1976–1992. Ophthalmology. 1994;101:1786–1792.PubMedGoogle Scholar
  168. 166.
    Highley M, Meller ST, Pinkerton CR. Seizures and cortical dysfunction following high-dose cisplatin administration in children. Med Pediatr Oncol. 1992;20:143–148.PubMedGoogle Scholar
  169. 167.
    Hill DL, Daroff RB, Ducros A, et al. Most cases labeled as “retinal migraine” are not migraine. J Neuroophthalmol. 2007;27:3–8.PubMedGoogle Scholar
  170. 168.
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Eng J Med. 1996;334:494–500.Google Scholar
  171. 169.
    Hirai T, Sato M, Kachi S, et al. Similar etiologies of functional visual loss observed in children and adults. Binocul Vis Strabismus Q. 2005;20:218–223.PubMedGoogle Scholar
  172. 170.
    Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9:4–13.PubMedGoogle Scholar
  173. 171.
    Hockaday JM. Basilar migraine in childhood. Dev Med Child Neurol. 1979;21:455–463.PubMedGoogle Scholar
  174. 172.
    Holmes G. Sabill memorial oration on local epilepsy. Lancet. 1927;1:957–962.Google Scholar
  175. 173.
    Holtzman RN, Goldensohn ES. Sensations of ocular movement in seizures originating in occipital lobe. Neurology. 1977;27:554–556.PubMedGoogle Scholar
  176. 174.
    Hoyt CS. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology. 1980;87:245–251.PubMedGoogle Scholar
  177. 175.
    Hughes MS, Lessell S. Trazadone-induced palinopsia. Arch Ophthalmol. 1990;108:399–400.PubMedGoogle Scholar
  178. 176.
    Hupp SL, Kline LB, Corbett JJ. Visual disturbances of migraine. Surv Ophthalmol. 1989;33:221–236.PubMedGoogle Scholar
  179. 177.
    Huppertz H-J, Franck P, Korinthenberg R, et al. Recurrent attacks of fear and visual hallucinations in a child. J Child Neurol. 2002;17:230–233.PubMedGoogle Scholar
  180. 178.
    Ip JM, Robaei D, Rochtchina E, et al. Prevalence of eye disorders in young children with eye strain complaints. Am J Ophthalmol. 2006;142:496–498.Google Scholar
  181. 179.
    International Classification of Headache Disorders, 2nd ed. Cephalalgia. 2004;24(Suppl 1):1–160.Google Scholar
  182. 180.
    Jacobson LK, Dutton GN. Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol. 2000;45:1–13.PubMedGoogle Scholar
  183. 181.
    Jäger HR, Giffin NJ, Goadsby PJ. Diffusion- and perfusion-weighted MR imaging and persistent migrainous visual disturbances. Cephalalgia. 2005;25:323–332.PubMedGoogle Scholar
  184. 182.
    Jorgensen KA, Sorensen P, Freund L. Effective leuko-chortico steroids on some coagulation tests. Acta Hematol [Basel]. 1982;68:39–42.Google Scholar
  185. 183.
    Josephson SA, Kirsch HE. Complex visual hallucinations as post-ictal cortical release phenomena. Neurocase. 2006;12:107–110.PubMedGoogle Scholar
  186. 184.
    Joutel A, Bousser MG, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40–45.PubMedGoogle Scholar
  187. 185.
    Kaiser HJ, Flammer J, Gasser P. Ocular vasospasm in children. Neuroophthalmology. 1993;13:263–267.Google Scholar
  188. 186.
    Kaminer Y, Hrecznyj B. Lysergic acid diethylamide induced chronic visual disturbances in an adolescent. J Nerv Ment Dis. 1991;179:173–174.PubMedGoogle Scholar
  189. 187.
    Kanavakis E, Xaidara A, Papathanasiou-Klontza D, et al. Alternerating hemplegia of childhood: a syndrome inherited with an autosomal dominant trait. Dev Med Child Neurol. 2003;45:833–836.PubMedGoogle Scholar
  190. 188.
    Kathol RG, Cox TA, Corbett JJ, et al. Functional visual loss. I: a true psychiatric disorder? Psychol Med. 1983;13:307–314.PubMedGoogle Scholar
  191. 189.
    Kathol RG, Cox TA, Corbett JJ, et al. Functional visual loss. II: psychiatric aspects in 42 patients followed for 4 years. Psychol Med. 1983;13:315–324.PubMedGoogle Scholar
  192. 190.
    Kathol RG, Cox TA, Corbett JJ, et al. Functional visual loss: follow-up of 42 cases. Arch Ophthalmol. 1983;101:729–735.PubMedGoogle Scholar
  193. 191.
    Katz B, Hoyt WF. Intrapapillary and peripapillary hemorrhage in young patients with uncomplicated posterior vitreous detachment: signs of vitreopapillary traction. Ophthalmology. 1995;102:340–352.Google Scholar
  194. 192.
    Kaube H, Keay KA, Hoskin KL, et al. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993;629:95–102.PubMedGoogle Scholar
  195. 193.
    Kaul S, Uparkar M, Sivaraman A, et al. Isolated foveal hypoplasia with good visual acuity and absence of nystagmus. JAAPOS. 2008 (in press)Google Scholar
  196. 194.
    Kennedy PG, Gardner-Thorpe C, Kocen RS. Subacute sclerosing panencephalitis presenting as transient homonymous hemianopia. J Neurol Neurosurg Psychiatry. 1983;46:186–187.Google Scholar
  197. 195.
    Kinast M, Lueders H, Rothner AD, et al. Benign focal epileptiform discharges in childhood migraine (BFEDC). Neurology. 1982;32:1309–1311.PubMedGoogle Scholar
  198. 196.
    Kinetz E. Is Hysteria Real? Brain Images Say Yes. New York Times; Sept. 26, 2006Google Scholar
  199. 197.
    King RA. Ocular signs and symptoms in children. Pediatr Clin North Am. 1993;40:753–766.PubMedGoogle Scholar
  200. 198.
    Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache. 1980;20:253–257.PubMedGoogle Scholar
  201. 199.
    Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol. 1979;97:1680–1686.PubMedGoogle Scholar
  202. 200.
    Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 1992;12:169–171.PubMedGoogle Scholar
  203. 201.
    Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience. 2001;106:793–800.PubMedGoogle Scholar
  204. 202.
    Kondo M, Ueno S, Piao C-H, et al. Occult macular dystrophy in an 11-year-old boy. Br J Ophthalmol. 2004;88:1602–1603.PubMedGoogle Scholar
  205. 203.
    Kooi KA. Episodic blindness as a late effect of head trauma: electrophysiological study of three cases. Neurology. 1970;20:569–573.PubMedGoogle Scholar
  206. 204.
    Kosnik E, Paulson GW, Laguna JF. Postictal blindness. Neurology. 1976;26:248–250.PubMedGoogle Scholar
  207. 205.
    Koutroumanidis M. Panayiotopoulos syndrome. Br Med J. 2008;2002(324):1228–1229.Google Scholar
  208. 206.
    Kruit MC, van Buehem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427–434.PubMedGoogle Scholar
  209. 207.
    Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–247.PubMedGoogle Scholar
  210. 208.
    Kupersmith MJ, Warren FA, Hass WK. The nonbenign aspects of migraine. Neuroophthalmology. 1987;7:1–10.Google Scholar
  211. 209.
    Kupersmith MJ. Neurovascular Neuro-ophthalmology. New York: Springer; 1993:452–453.Google Scholar
  212. 210.
    Laffi GL, Safran AB. Persistent visual hallucinations following hashish consumption. Br J Ophthalmol. 1993;77:601–603.PubMedGoogle Scholar
  213. 211.
    Lagae L. What’s new in: “genetics in childhood epilepsy”. Eur J Pediatr. 2008;167:715–722.PubMedGoogle Scholar
  214. 212.
    Lai TY, Chan W-M, Lai RY, et al. The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol. 2007;52:61–96.PubMedGoogle Scholar
  215. 213.
    Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain. 1976;99:719–734.PubMedGoogle Scholar
  216. 214.
    Lanska DJ, Lanska MJ, Mendez MM. Brainstem auditory hallucinosis. Neurology. 1987;37:1685.PubMedGoogle Scholar
  217. 215.
    Lanska DJ, Lanska MJ. Visual release hallucinations in juvenile neuronal ceroid lipofuscinosis. Pediatr Neurol. 1993;9:316–317.PubMedGoogle Scholar
  218. 216.
    Lapkin ML, Golden GS. Basilar artery migraine. Am J Dis Child. 1978;132:278–281.PubMedGoogle Scholar
  219. 217.
    Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry. 1941;46:331–339.Google Scholar
  220. 218.
    Lauritzen M. Cortical spreading depression as a putative migraine mechanism. Trends Neurosci. 1987;10:8–13.Google Scholar
  221. 219.
    Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain. 1994;117:199–210.PubMedGoogle Scholar
  222. 220.
    Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by xenon 133 inhalation and emission tomography. Brain. 1984;107:447–461.PubMedGoogle Scholar
  223. 221.
    Lawden MC, Eke T, Degg C, et al. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry. 1999;67:716–722.PubMedGoogle Scholar
  224. 222.
    Ledo KA. Spreading depression of activity in cerebral cortex. J Neurophysiol. 1944;7:359–390.Google Scholar
  225. 223.
    Lee M, SantaCruz K, Brace J, et al. Progressive visual loss in a man with leukemia. Presented at the Frank B Walsh Society Meeting. Nevada: Lake Tahoe; Feb. 22, 2008Google Scholar
  226. 224.
    Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148.PubMedGoogle Scholar
  227. 225.
    Lepore FE. Spontaneous visual phenomenon with visual loss: 104 patients with lesions of the retinal and neuro-afferent pathways. Neurology. 1990;44:444–447.Google Scholar
  228. 226.
    Lepore FE. Uhthoff’s symptoms in disorders of the anterior visual pathways. Neurology. 1994;44:1036–1038.PubMedGoogle Scholar
  229. 227.
    Lessell S. Higher disorders of visual function: positive phenomenon. In: Glaser JS, Smith JL, eds. Neuro-ophthalmology: Symposium of the University of Miami in the Bascom Palmer Eye Institute, VIII. St. Louis, MO: C.V. Mosby; 1975:27–44.Google Scholar
  230. 228.
    Lessell S, Cohen MM. Phosphenes induced by sound. Neurology. 1979;38:1524–1527.Google Scholar
  231. 229.
    Levi L, Miller NR. Visual illusions associated with previous drug allergy. J Clin Neuroophthalmol. 1990;10:103–110.PubMedGoogle Scholar
  232. 230.
    Lewis D, Ashwal S, Dahl G, et al. American Academy of Neurology Practice parameter: evaluation of children and adolescents with recurrent headaches. Neurology. 2002;59:490–498.PubMedGoogle Scholar
  233. 231.
    Lewis D, Ashwal S, Hershey A, et al. American Academy of Neurology Practice Parameter: pharmacological treatment of migraine headache in children and adolescents. Neurology. 2004;63:2215–2224.PubMedGoogle Scholar
  234. 232.
    Lewis DW, Diamond S, Scott D, et al. Prophylactic treatment of pediatric migraine. Headache. 2004;44:230–237.PubMedGoogle Scholar
  235. 233.
    Lewis DW, Kellstein D, Dahl G, et al. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780–786.PubMedGoogle Scholar
  236. 234.
    Lewis RA, Vijayair N, Watson C, et al. Visual field loss in migraine. Ophthalmology. 1989;96:321–326.PubMedGoogle Scholar
  237. 235.
    Liaw SB, Shen EY. Alice in Wonderland syndrome as a presenting symptom of EBV infection. Pediatr Neurol. 1991;7:464–466.PubMedGoogle Scholar
  238. 236.
    Lim SA, Siatkowski RM, Farris BK. Functional visual loss in adults and children patient characteristics, management, and outcomes. Ophthalmology. 2005;112:1821–1828.PubMedGoogle Scholar
  239. 237.
    Limmroth V, May A, Auerbach P, et al. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996;138:60–65.PubMedGoogle Scholar
  240. 238.
    Lippman CW. Certain hallucinations peculiar to migraine. J Nerv Ment Dis. 1952;116:3466.Google Scholar
  241. 239.
    Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA. 2004;28:493–494.Google Scholar
  242. 240.
    Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–657.PubMedGoogle Scholar
  243. 241.
    Lipton RB, Ottman R, Ehrenberg BL, et al. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994;44(Suppl 7):528–532.Google Scholar
  244. 242.
    Little RD, Goldstein JL. Alexia without agraphia in a child with acute disseminated encephalomyelitis. Neurology. 2006;67:725.PubMedGoogle Scholar
  245. 243.
    Liu GT, Schatz NJ, Galetta SL, et al. Persistent positive visual phenomena in migraine. Neurology. 1995;45:664–668.PubMedGoogle Scholar
  246. 244.
    Loewenstein JI. Visual hallucinations in patients with choroidal neovascularization. JAMA. 1994;272:243.PubMedGoogle Scholar
  247. 245.
    Lorentzen SE. Drusen of the optic disk. Dan Med Bull. 1967;14:293–298.Google Scholar
  248. 246.
    Lowery RS, Atkinson D, Lambert SR. Cryptic cerebral impairment in children. Br J Ophthalmol. 2006;90:960–963.PubMedGoogle Scholar
  249. 247.
    Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50:109–115.PubMedGoogle Scholar
  250. 248.
    Ludwig BI, Marsan CA. Clinical ictal patterns in epileptic patients with occipital electroencephalographic foci. Neurology. 1975;25:463–471.PubMedGoogle Scholar
  251. 249.
    MacDonald JT. Childhood migraine: differential diagnosis and treatment. Postgrad Med. 1986;80:301–4,306PubMedGoogle Scholar
  252. 250.
    MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34:581–582.PubMedGoogle Scholar
  253. 251.
    Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin: asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ. 1998;316:233.PubMedGoogle Scholar
  254. 252.
    Macnab AJ, Bennett M. Refrigerator blindness: selective loss of visual acuity in association with a common foraging behavior. CMAJ. 2005;173:1494–1495.PubMedGoogle Scholar
  255. 253.
    Maitland CG. Ocular motility in childhood migraine. Presented at the North American Neuro-Ophthalmological Society Meeting. CA: Rancho Bernardo; Feb. 23–27, 1992Google Scholar
  256. 254.
    Manford M, Andermann F. Complex visual hallucinations: clinical and neurobiological insights. Brain. 1998;121:1819–1840.PubMedGoogle Scholar
  257. 255.
    Mantyjärvi MI. The amblyopic schoolgirl syndrome. J Pediatr Ophthalmol Strabismus. 1981;18:6.Google Scholar
  258. 256.
    Mark AS, Casselman J, Brown D, et al. Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MRI images. AJNR Am J Neuroradiol. 1998;19:1887–1891.PubMedGoogle Scholar
  259. 257.
    Markowitz S, Saito K, Moskowitz MA, et al. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalagia. 1988;8:83–91.Google Scholar
  260. 258.
    Marra TR, Shah M, Mikus MA. Transient cortical blindness due to hypertensive encephalopathy. Magnetic resonance imaging correlation. J Clin Neuroophthalmol. 1993;13:35–37.PubMedGoogle Scholar
  261. 259.
    Martinovic Z. Panayiotopoulos syndrome. Lancet. 2001;358:69.PubMedGoogle Scholar
  262. 260.
    Martins-Ferreira H, de Castro GO. Light scattering changes accompanying spreading depression in isolated retina. J Neurophysiol. 1966;29:715–726.PubMedGoogle Scholar
  263. 261.
    Martins-Ferreira H, Nedergaard M, Nicholson C. Perspectives on spreading depression. Brain Res Rev. 2000;32:215–234.PubMedGoogle Scholar
  264. 262.
    Martyn LJ. Discussion of Catalano et al. Functional visual loss in children. Ophthalmology. 1986;93:390.Google Scholar
  265. 263.
    Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital sitmulators: a PET study. Brain. 2004;127:220–230.PubMedGoogle Scholar
  266. 264.
    Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology. 1991;41:1043–1046.PubMedGoogle Scholar
  267. 265.
    Matthews GP, Sandberg MA, Berson EL. Foveal cone electroretinograms in patients with central visual loss of unexplained etiology. Arch Ophthalmol. 1992;110:1568–1570.PubMedGoogle Scholar
  268. 266.
    McKendrick AM, Badcock DR. Decreased visual field sensitivity measured 1 day, 1 week, after migraine. Invest Ophthalmol Vis Sci. 2004;45:1061–1070.PubMedGoogle Scholar
  269. 267.
    McKillop E, Dutton GN. Impairment of vision in children due to damage to the brain: a practical approach. Br Ir Orthopt J. 2008;5:8–14.Google Scholar
  270. 268.
    Meldrum BS, Brierly JB. Prolonged epileptic seizures in primates. Arch Neurol. 1973;28:10–17.PubMedGoogle Scholar
  271. 269.
    Mewasingh LD, Kornreich C, Christiaens F, et al. Pediatric phantom vision (Charles Bonnet) syndrome. Pediatr Neurol. 2002;26:143–145.PubMedGoogle Scholar
  272. 270.
    Michaelides M, Holder GE, Bradshaw K, et al. Oligocone trichromacy: a rare and unusual cone dysfunction syndrome. Br J Ophthalmol. 2004;88:497–500.PubMedGoogle Scholar
  273. 271.
    Mierzwiński J, Polak M, Dalke K, et al. Benign paroxysmal vertigo of childhood. Otolaryngol Pol. 2007;61:307–310.PubMedGoogle Scholar
  274. 272.
    Mikati MA, Maguire H, Barlow CF, et al. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy: chromosomal studies; and physiologic investigations. Neurology. 1992;42:2251–2257.PubMedGoogle Scholar
  275. 273.
    Miller BW. A review of practical tests for ocular malingering and hysteria. Surv Ophthalmol. 1973;17:241–246.PubMedGoogle Scholar
  276. 274.
    Miller NR. Walsh and Hoyt’s Clinical Neuro-ophthalmology, III. 4th ed. Baltimore: Williams and Wilkins; 1988:1398.Google Scholar
  277. 275.
    Miller SP, Sanchez-Avalos J, Stefanski T, et al. Coagulation disorders in cancer I: clinical and laboratory studies. Cancer. 1967;20:1452–1465.PubMedGoogle Scholar
  278. 276.
    Miyake Y, Horiguchi M, Tomita N, et al. Occult macular dystrophy. Am J Ophthalmol. 1996;122:644–653.PubMedGoogle Scholar
  279. 277.
    Miyamoto S, Kikuchi H, Karasawa J, et al. Study of the posterior circulation in moyamoya disease. Part 2: visual disturbances and surgical treatment. J Neurosurg. 1986;65:454–460.PubMedGoogle Scholar
  280. 278.
    Miyake Y, Ichikawa K, Shiose Y, et al. Hereditary macular dystrophy without visible fundus abnormality. Am J Ophthalmol. 1989;1108:292–299.Google Scholar
  281. 279.
    Monteiro JM, Rosas MJ, Correia AP, et al. Migraine and intracranial vascular malformations. Headache. 1993;33:563–565.PubMedGoogle Scholar
  282. 280.
    Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia. 1992;12:238–243.PubMedGoogle Scholar
  283. 281.
    Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol. 1992;34:1096–1101.Google Scholar
  284. 282.
    Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–154.PubMedGoogle Scholar
  285. 283.
    Nadvi SS, van Dellen JR. Transient peduncular hallucinations secondary to brainstem compression by a medulloblastoma. Surg Neurol. 1994;41:250–252.PubMedGoogle Scholar
  286. 284.
    Nagendran K, Prior PF, Rossiter MA. Benign occipital epilepsy of childhood: a family study. J R Soc Med. 1989;82:684–685.PubMedGoogle Scholar
  287. 285.
    Natowicz M, Kelley RI. Mendelian etiologies of stroke. Ann Neurol. 1987;22:175–192.PubMedGoogle Scholar
  288. 286.
    Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia. 2004;24:83–91.PubMedGoogle Scholar
  289. 287.
    Newmark ME. Visual hallucinations. JAMA. 1987;257:82. Letter.Google Scholar
  290. 288.
    Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusion. Semin Neurol. 2000;20:111–121.PubMedGoogle Scholar
  291. 289.
    Nyhold DR, Dawkins JL, Brimage PJ, et al. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet. 1998;7:459–463.Google Scholar
  292. 290.
    O’Connor PJ, Tredici TJ. Acephalgic migraine: fifteen years experience. Ophthalmology. 1981;88:999–1003.PubMedGoogle Scholar
  293. 291.
    O’Hara MA, Anderson RT, Brown D. MR imaging in ophthalmoplegic migraine of children. Presented as a poster at the American Association of Pediatric Ophthalmology and Strabismus. Orlando, FL.; April 5–9, 1995Google Scholar
  294. 292.
    O’Hare AE, Dutton GN, Green D, et al. Evolution of a form of pure alexia without agraphia in a child sustaining occipital lobe infarction at 21/2 years. Dev Med Child Neurol. 1998;40:417–420.PubMedGoogle Scholar
  295. 293.
    Olbrich H, Engelmeier MP, Pauleikhoff D, et al. Visual hallucinations in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 1987;225:217–220.PubMedGoogle Scholar
  296. 294.
    Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344–352.PubMedGoogle Scholar
  297. 295.
    Olesen J. Migraine and regional cerebral blood flow. Trends Neurosci. 1985;8:318–322.Google Scholar
  298. 296.
    Olness K, McDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593–597.PubMedGoogle Scholar
  299. 297.
    Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type 2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543–552.PubMedGoogle Scholar
  300. 298.
    Osako M, Harasawa K, Suzuki H, et al. The characteristics of static visual fields in children with psychogenic visual disturbances. Jpn J Ophthalmol. 2000;44:516–519.PubMedGoogle Scholar
  301. 299.
    O’Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol. 1992;76:660–662.PubMedGoogle Scholar
  302. 300.
    Panayiotopoulos CP. The birth and evolution of the concept of Panayiotopoulos syndrome. Epilepsia. 2007;48:1041–1043.PubMedGoogle Scholar
  303. 301.
    Panayiotopoulos CP. Difficulties in differentiating migraine in epilepsy based on clinical and EEG findings. In: Anderman F, Lugaressi E, eds. Migraine in Epilepsy. Boston: Butterworth; 1987.Google Scholar
  304. 302.
    Panayiotopoulos CP. Benign childhood epilepsy with occipital paroxysms: a 15-year prospective clinical and electroencephalographic study. Ann Neurol. 1989;26:51–56.PubMedGoogle Scholar
  305. 303.
    Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry. 1994;57:1371–1374.PubMedGoogle Scholar
  306. 304.
    Paquier PF, De Smet HJ, Mariën P, et al. Acquired alexia without agraphia syndrome in childhood. J Child Neurol. 2006;21:324–330.PubMedGoogle Scholar
  307. 305.
    Parisi P, Pagani J, Galiffa S, et al. Migrainous vertigo unresponsive to antimigraine therapy in a child with “asymptomatic” cerebellar lesion: casual or causal association? Cephalalgia. 2005;25:831–835.PubMedGoogle Scholar
  308. 306.
    Parisi P, Villa MP, Pelliccia A. Panayiotopoulos syndrome: diagnosis and management. Neurol Sci. 2007;28:72–79.PubMedGoogle Scholar
  309. 307.
    Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481–488.PubMedGoogle Scholar
  310. 308.
    Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia. 1983;3:129–134.PubMedGoogle Scholar
  311. 309.
    Penfield W, Erickson TC. Epilepsy and Cerebral Localization. Baltimore: Charles C. Thomas; 1941:101–103.Google Scholar
  312. 310.
    Penfield W, Kristiansen K. Seizure patterns. Epileptic Seizure Patterns. Springfield, IL: Charles C. Thomas; 1951:16–84.Google Scholar
  313. 311.
    Penfield W, Parot P. The brain’s record of auditory and visual experience. Brain. 1963;86:595–696.PubMedGoogle Scholar
  314. 312.
    Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44:53–64.PubMedGoogle Scholar
  315. 313.
    Petzold A, Islam N, Plant GT. Video reconstruction of vasospastic transient monocular blindness. N Engl J Med. 2003;348:1609–1610.PubMedGoogle Scholar
  316. 314.
    Pfaender M, E’Souza WJ, Trost N, et al. Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and celiac disease: a case series. J Neurol Neurosurg Psychiatry. 2004;75:1623–1625.PubMedGoogle Scholar
  317. 315.
    Pochedly C, Miller SP, Mehta A. “Hypercoagulable state” in children with acute leukemia or disseminated solid tumors. Oncology. 1973;28:517–522.PubMedGoogle Scholar
  318. 316.
    Ponjavic V, Andréasson S. Multifocal ERG and full-field ERG, in patients on long-term vigabatrin medication. Doc Ophthalmol. 2001;102:63–72.PubMedGoogle Scholar
  319. 317.
    Porciatti V, Bonanni P, Fiorentini A, et al. Lack of cortical contrast gain in human photosensitive epilepsy. Nat Neurosci. 2000;3:259–263.PubMedGoogle Scholar
  320. 318.
    Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506–510.PubMedGoogle Scholar
  321. 319.
    Priest JR, Ramsay NK, Latchaw RE, et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer. 1980;46:1548–1554.PubMedGoogle Scholar
  322. 320.
    Priest JR, Ramsay NK, Bennett AK, et al. The effect of l-asparaginase on antithrombin, plasminogen, and plasma-coagulation during therapy for acute lymphoblastic leukemia. J Pediatr. 1982;100:990–995.PubMedGoogle Scholar
  323. 321.
    Pui C-H, Jackson CW, Chesney C, et al. Sequential changes in platelet function in coagulation in leukemic children treated with l-asparaginase prednisone of vincristine. J Clin Oncol. 1983;1:380–385.PubMedGoogle Scholar
  324. 322.
    Purvin V, Selky AK. Palinopsia following LSD ingestion. Presented as a poster at the North American Neuro-ophthalmology Society Meeting. Tucson, AZ.; Feb. 19–23, 1995Google Scholar
  325. 323.
    Rabinowicz IM. Amblyopia. In: Harley RD, ed. Pediatric Ophthalmology, I. 2nd ed. Philadelphia: WB Saunders; 1983:293–348.Google Scholar
  326. 324.
    Rada RT, Krill AE, Meyer GG, et al. Visual conversion reaction in children. II. Follow-up. Psychosomatics. 1973;14:271–276.PubMedGoogle Scholar
  327. 325.
    Rada RT, Meyer GG, Kellner R. Visual conversion reaction in children and adults. J Nerv Ment Dis. 1978;166:580–587.PubMedGoogle Scholar
  328. 326.
    Rafay MF, Armstrong D, deVeber G, et al. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J Child Neurol. 2006;21:8–16.PubMedGoogle Scholar
  329. 327.
    Ramadan NM, Tietjen GE, Levine SR, et al. Scintillating scotomata associated with internal carotid artery dissection: report of three cases. Neurology. 1991;41:1084–1087.PubMedGoogle Scholar
  330. 328.
    Ramsay NK, Coccia PF, Krivit W, et al. The effect of l-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia. J Cancer. 1977;40:1398–1401.Google Scholar
  331. 329.
    Raskin NH, Schwartz RK. Ice-pick like pain. Neurology. 1980;30:203.PubMedGoogle Scholar
  332. 329a.
    Riedel KG, Zwaan J, Kenyon KR, et al. Ocular abnormalities in mucolipidosis IV. Am J Ophthalmol. 1985;99(2):125–136.PubMedGoogle Scholar
  333. 330.
    Rho JM, Chugani HT. Alternating hemiplegia of childhood: insights into its pathophysiology. J Child Neurol. 1998;13:39–45.PubMedGoogle Scholar
  334. 331.
    Riaz G, Selhorst JB, Hennessey JJ. Meningeal lesions mimicking migraine. Neuroophthalmology. 1991;11:41–48.Google Scholar
  335. 332.
    Riela AR, Roach ES. Etiology of strokes in children. J Child Neurol. 1993;8:201–220.PubMedGoogle Scholar
  336. 333.
    Rinalduzzi S, Valeriani M, Vigevano F. Brainstem dysfunction in alternating hemiplegia of childhood: a neurophysiologic study. Cephalalgia. 2006;26:511–529.PubMedGoogle Scholar
  337. 334.
    Rippe DJ, Edwards MK, Schrodt JF, et al. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. JCAT. 1988;12:1078–1081.Google Scholar
  338. 335.
    Robertson WC, Schnitzier ER. Ophthalmoplegic migraine in infancy. Pediatrics. 1978;61:886–888.PubMedGoogle Scholar
  339. 336.
    Rolak AL, Baram TZ. Visual hallucinations: more diagnosis. JAMA. 1987;257:2036. Letter.Google Scholar
  340. 337.
    Rossi LN, Vassella F. Headache in children with brain tumors. Childs Nerv Syst. 1989;5:307–309.PubMedGoogle Scholar
  341. 338.
    Rossi LN, Penzien JM, Deonna T, et al. Does migraine-related stroke occur in childhood? Dev Med Child Neurol. 1990;32:1016–1021.PubMedGoogle Scholar
  342. 338a.
    Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology 2003;110(6)1151–1158.PubMedGoogle Scholar
  343. 339.
    Rummelt V, Folberg R, Ionasescu V, et al. Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology. 1993;100:1757–1766.PubMedGoogle Scholar
  344. 340.
    Russell WR, Whitty CW. Studies in traumatic epilepsy. 3: visual fits. J Neurol Neurosurg Psychiatry. 1955;18:79–96.PubMedGoogle Scholar
  345. 341.
    Rüther K, Pung T, Kellner U, et al. Electrophysiologic evaluation of patients with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol. 1998;116:817–819.Google Scholar
  346. 342.
    Sadeh M, Goldhammer Y, Kuritsky A. Postictal blindness in adults. J Neurol Neurosurg Psychiatry. 1983;46:566–569.PubMedGoogle Scholar
  347. 343.
    Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984;16:489–494.PubMedGoogle Scholar
  348. 344.
    Saidkasimova S, Bennett DM, Butler S, et al. Cognitive visual impairment with good visual acuity in children with periventricular white matter injury. A series of 7 cases. J AAPOS. 2007;11:426–430.PubMedGoogle Scholar
  349. 345.
    Salanova V, Andermann F, Olivier A, et al. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Brain. 1992;115:1655–1680.PubMedGoogle Scholar
  350. 346.
    Sanguineti B, Crovato F, De Marchi R, et al. Alice in Wonderland syndrome in a patient with infectious mononucleosis. J Infect Dis. 1983;147:782.PubMedGoogle Scholar
  351. 347.
    Sanner G, Bergström B. Benign paroxysmal torticollis in infancy. Acta Paediatr Scand. 1979;68:219–223.PubMedGoogle Scholar
  352. 348.
    Santhouse AM, Howard RJ, Ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000;123:2055–2064.PubMedGoogle Scholar
  353. 349.
    Santos CH, Gomes AIL, Pereira SA, et al. Bilateral occipital calcification, epilepsy, and celiac disease: case report. Arq Neuropsiquiatr. 2002;60:840–843.PubMedGoogle Scholar
  354. 350.
    Savitsky N, Tarachow S. Lilliputian hallucinations during convalescence from scarlet fever in a child. J Nerv Ment Dis. 1941;93:310–312.Google Scholar
  355. 351.
    Schlaegel TF Jr, Quilala FV. Hysterical amblyopia. Arch Ophthalmol. 1955;54:875–884.Google Scholar
  356. 352.
    Schreier HA, Libow JA. Munchausen by proxy syndrome: a modern pediatric challenge. J Pediatr. 1994;125:S110-S115.PubMedGoogle Scholar
  357. 353.
    Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J AAPOS. 1998;2:310–313.PubMedGoogle Scholar
  358. 354.
    Scott JA, Egan RA. Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol. 2003;135:670–675.PubMedGoogle Scholar
  359. 355.
    Scully R, Mark E, McNeely W, et al. Case Records of the Massachusetts General Hospital. Case 39–1998. N Engl J Med. 1998;339:1914–1923.Google Scholar
  360. 356.
    Selby G. Migraine and Its Variants. Sydney: Adis Health Science Press; 1983:33.Google Scholar
  361. 357.
    Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;23:23–32.PubMedGoogle Scholar
  362. 358.
    Selhorst JB, Saul RF, Waybright EA. Optic nerve conduction: opposing effects of exercise and hyperventilation. Trans Am Neurol Assoc. 1981;106:101–105.Google Scholar
  363. 359.
    Seybold ME, Rosen PN. Peripapillary staphyloma and amaurosis fugax. Ann Ophthalmol. 1977;9:1139–1141.PubMedGoogle Scholar
  364. 360.
    Shaikh S, Trese MT. New insights into progressive visual loss in adult retinopathy of prematurity. Arch Ophthalmol. 2004;122:404–406.PubMedGoogle Scholar
  365. 361.
    Shepherd AJ. Colour vision in migraine: selective deficits for S-cone discriminations. Cephalalgia. 2005;25:412–423.PubMedGoogle Scholar
  366. 362.
    Shutter LA, Green JP, Newman NJ, et al. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology. 1993;43:2417–2418.PubMedGoogle Scholar
  367. 363.
    Smith TJ, Baker RS. Perimetric findings in functional disorders using automated techniques. Ophthalmology. 1987;94:1562–1566.PubMedGoogle Scholar
  368. 364.
    Snebold NG, Rizzo JF, Lessell S, et al. Transient visual loss in ornithine transcarbamoylase deficiency. Am J Ophthalmol. 1987;104:407–412.PubMedGoogle Scholar
  369. 365.
    Solomon GD. Migrainous periorbital ecchymosis. Headache. 1989;29:328. Abstract.Google Scholar
  370. 366.
    Somerville BW. Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust. 1976;1:865–866.PubMedGoogle Scholar
  371. 367.
    Sorensen JB, Parnas J. A clinical study of 44 patients with juvenile amaurotic familial idiocy. Acta Psychiatr Scand. 1979;59:449–461.PubMedGoogle Scholar
  372. 368.
    Steg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology. 1991;141:1156.Google Scholar
  373. 369.
    Steinberg H. Erythropoietin and visual hallucinations. N Engl J Med. 1991;325:285.PubMedGoogle Scholar
  374. 370.
    Stellingwerf C. Charles Bonnet Syndrome in Children. Vilamoura, Portugal: European Paediatric Ophthalmological Society; Oct. 5–7, 2006Google Scholar
  375. 371.
    Stommel JE, Ward TN, Harris RD. MRI findings in a case of ophthalmoplegic migraine. Headache. 1993;33:234–237.PubMedGoogle Scholar
  376. 372.
    Stone EM, Nichols BE, Kimura AE, et al. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol. 1994;112:765–772.PubMedGoogle Scholar
  377. 373.
    Strauss H. Paroxysmal blindness. Electroencephalogr Clin Neurophysiol. 1963;15:921. Abstract.Google Scholar
  378. 374.
    Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007;4:267–273.PubMedGoogle Scholar
  379. 375.
    Swainmann KF, Yizchak F. Seizure headaches in children. Dev Med Child Neurol. 1978;20:580–585.Google Scholar
  380. 376.
    Taich A, Crowe S, Kosmorsky GS, et al. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J AAPOS. 2004;8:457–461.PubMedGoogle Scholar
  381. 377.
    Takano T, Tian G-F, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007;10:754–762.PubMedGoogle Scholar
  382. 378.
    Tamhankar MA, Coslett HB, Fisher MJ, et al. Alexia without agraphia following biopsy of a left thalamic tumor. Pediatr Neurol. 2004;30:140–142.PubMedGoogle Scholar
  383. 379.
    Tasman W, Brown GC. Progressive visual loss in adults with retinopathy of prematurity (ROP). Trans Am Ophthalmol Soc. 1988;86:367–379.PubMedGoogle Scholar
  384. 380.
    Taylor D. Pediatric Ophthalmology. Boston: Blackwell Publications; 1990:568–569.Google Scholar
  385. 381.
    Terwindt GM, Ophoff RA, van Eijk R, et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology. 2001;56:1028–1032.PubMedGoogle Scholar
  386. 382.
    Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migraves) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia. 1984;4:107–111.PubMedGoogle Scholar
  387. 383.
    Thompson HS. Functional visual loss. Am J Ophthalmol. 1985;100:209–213.PubMedGoogle Scholar
  388. 384.
    Thomsen LL, Ostergaard E, Olesen J, et al. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology. 2003;60:595–601.PubMedGoogle Scholar
  389. 385.
    Tietjen GE. Migraine as a systemic disorder. Neurology. 2007;68:1555–1556.PubMedGoogle Scholar
  390. 386.
    Tippin J, Corbett JJ, Kerber RE, et al. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol. 1989;26:69–77.PubMedGoogle Scholar
  391. 387.
    Todd J. The syndrome of Alice in Wonderland. Can Med Assoc J. 1955;73:701–704.PubMedGoogle Scholar
  392. 388.
    Tomsak RL, Jergens PB. Benign recurrent transient monocular blindness: a possible variant of acephalgic migraine. Headache. 1987;27:66–69.PubMedGoogle Scholar
  393. 389.
    Tornqvist G. Paralysis of accommodation. Acta Ophthalmol. 1971;49:702–706.Google Scholar
  394. 390.
    Troost BT, Newton TH. Occipital lobe arteriovenous malformations. Arch Ophthalmol. 1975;93:250–265.PubMedGoogle Scholar
  395. 391.
    Troost BT, Mark LE, Maroon JC. Resolution of classic migraine after removal of an occipital lobe AVM. Ann Neurol. 1979;5:199–201.PubMedGoogle Scholar
  396. 392.
    Uliss AE, Moore AT, Bird AC. The dark choroid in posterior retinal dystrophies. Ophthalmology. 1987;94:1423–1427.PubMedGoogle Scholar
  397. 393.
    Uneri A, Turkdogan D. Evaluation of vestibular functions in children with vertigo attacks. Arch Dis Child. 2003;88:510–511.PubMedGoogle Scholar
  398. 394.
    van Balen AT, Slijper FE. Psychogenic amblyopia in children. J Pediatr Ophthalmol Strabismus. 1978;15(3):164–167.PubMedGoogle Scholar
  399. 395.
    van Bogaert L. L’hallucinose pedunculaire. Rev Neurol. 1927;43:608–617.Google Scholar
  400. 396.
    van de Ven RCG, Kaja S, Plomp JJ, et al. Genetic models of migraine. Arch Neurol. 2007;64:643–646.PubMedGoogle Scholar
  401. 397.
    van Gelder P, Geurs Ph, Kho GS, et al. Cortical blindness and seizures following cisplatin treatment: both of epileptic origin? Eur J Cancer. 1993;29:1497–1498.Google Scholar
  402. 398.
    van Harreveld A. Two mechanisms for spreading depression in the chick retina. J Neurobiol. 1978;6:419–431.Google Scholar
  403. 399.
    van Harreveld A. The nature of chick’s magnesium sensitive retinal spreading depression. J Neurobiol. 1984;15:333–344.PubMedGoogle Scholar
  404. 400.
    Van Lith GH. General cone dysfunction without achromatopsia. In: Pearlman JT, ed. 10th ISCERG Symposium-Color Vision Deficiencies. XII. Amsterdam: Kluver Academic Publishers; 1995:203–210.Google Scholar
  405. 401.
    Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007;68:1563–1570.PubMedGoogle Scholar
  406. 402.
    Vega-Talbot ML, Duchowny M, Jayakar P. Orbitofrontal seizures presenting with ictal visual hallucinations and interictal psychosis. Pediatr Neurol. 2006;35:78–81.PubMedGoogle Scholar
  407. 403.
    Velentgas P, Cole A, Mo J, et al. Severe vascular events in migraine patients. Headache. 2004;44:642–651.PubMedGoogle Scholar
  408. 404.
    Vijayan N. Ophthalmoplegic migraine: ischemic or compressive neuropathy? Headache. 1980;20:300–304.PubMedGoogle Scholar
  409. 405.
    Vike J, Jabbari B, Maitland CG. Auditory-visual synesthesia: report of a case with intact visual pathways. Arch Neurol. 1984;41:680–681.PubMedGoogle Scholar
  410. 406.
    von Brevern M, Zeise D, Neuheuser H, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128:365–374.Google Scholar
  411. 407.
    von Noorden GK. Idiopathic amblyopia. Am J Ophthalmol. 1985;100:214–217.Google Scholar
  412. 408.
    Walsh JP, O’Doherty DS. A possible explanation of the mechanism of ophthalmoplegic migraine. Neurology. 1960;10:1079–1084.PubMedGoogle Scholar
  413. 409.
    Warrell RP, Berman E. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. J Clin Oncol. 1986;4:76–79.Google Scholar
  414. 410.
    Waxman SG. Clinical course and electrophysiology of multiple sclerosis. In: Waxman SG, ed. Functional Recovery in Neurological Disease. New York: Raven Press; 1988:157–184.Google Scholar
  415. 411.
    Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–660.PubMedGoogle Scholar
  416. 412.
    Weinberger LM, Grant FC. Visual hallucinations and their neuro-optical correlates. Arch Ophthalmol. 1940;23:166–199.Google Scholar
  417. 413.
    Welch KM, D’Andrea G, Tepley N, et al. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990;8:817–828.PubMedGoogle Scholar
  418. 414.
    Welch KM, Barkley GL, Tepley N, et al. Central neurogenic mechanisms of migraine. Neurology. 1993;43(Suppl 3):S21-S25.PubMedGoogle Scholar
  419. 415.
    Welch KM. Drug therapy of migraine. N Engl J Med. 1993;329:1476–1483.PubMedGoogle Scholar
  420. 416.
    Weleber RG, Shults WT. Digoxin retinal toxicity. Clinical and electrophysiological evaluation of a cone dysfunction syndrome. Arch Ophthalmol. 1981;99:1568–1572.PubMedGoogle Scholar
  421. 417.
    Weleber RG, Carr RE, Murphey WH, et al. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993;11:1531–1542.Google Scholar
  422. 418.
    Weleber RG. Stargardt’s macular dystrophy. Arch Ophthalmol. 1994;112:752–753.PubMedGoogle Scholar
  423. 419.
    Weller M, Wiedemann P. Visual hallucinations. An outline of etiological and pathogenetic concepts. Int Ophthalmol Clin. 1989;13:193–199.Google Scholar
  424. 420.
    Wertenbaker C, Gutman I. Unusual visual symptoms. Surv Ophthalmol. 1985;29:297–299.PubMedGoogle Scholar
  425. 421.
    Wessman M, Kallela M, Kaunisto MA, et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet. 2002;70:652–662.PubMedGoogle Scholar
  426. 422.
    White CP, Jan JE. Visual hallucinations after acute visual loss in a young child. Dev Med Child Neurol. 1992;34:252–265.Google Scholar
  427. 423.
    Williamson DJ, Hargreaves RJ, Hill RG, et al. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural blood vessel diameter in the anaesthetized rat. Cephalalgia. 1997;17:518–524.PubMedGoogle Scholar
  428. 424.
    Williamson PD, Boone PA, Spencer DD, et al. Occipital and parietal epilepsy. Epilepsy. 1988;29:682.Google Scholar
  429. 425.
    Williamson PD, Thadani VM, Darcy TM, et al. Occipital lobe epilepsy: clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol. 1992;31:3–13.PubMedGoogle Scholar
  430. 426.
    Winterkorn JM. “Retinal Migraine” is an oxymoron. J Neuroophthalmol. 2007;27:1–2.PubMedGoogle Scholar
  431. 427.
    Winterkorn JM, Kupersmith MJ, Wirtschafter JD, et al. Treatment of vasospastic amaurosis fugax with calcium channel blockers. N Engl J Med. 1993;329:396–398.PubMedGoogle Scholar
  432. 428.
    Winterkorn JM. Vasospasm or migraine? Presented at the American Academy of Ophthalmology. San Francisco; November 1994Google Scholar
  433. 429.
    Winterkorn JM, Burde RM. Vasospasm-not migraine-in the anterior visual pathway. Ophthalmol Clin North Am. 1996;9:393–405.Google Scholar
  434. 430.
    Wirrell EC, Hamiwka LD, Hamiwka LA, et al. Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci. 2007;34:316–321.PubMedGoogle Scholar
  435. 431.
    Wisotsky BJ, Engel HM. Transesophageal echocardiography in the diagnosis of branch retinal artery obstruction. Am J Ophthalmol. 1993;115:653–656.PubMedGoogle Scholar
  436. 432.
    Wolff HG. Headache and Other Head Pain. 2nd ed. New York: Oxford University Press; 1963.Google Scholar
  437. 433.
    Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689–1692.PubMedGoogle Scholar
  438. 434.
    Wraith E. Ornithine carbamoyltransferase deficiency. Arch Dis Child. 2001;84:84–89.PubMedGoogle Scholar
  439. 435.
    Wunderlich G, Suchan B, Volkmann J, et al. Visual hallucinations in recovery from cortical blindness. Arch Neurol. 2000;57:561–565.PubMedGoogle Scholar
  440. 436.
    Wynick S, Hobson RP, Jones RB. Psychogenic disorders of vision in childhood (“visual conversion reactions”): perspectives from adolescence: a research note. J Child Psychol Psychiatry. 1997;38:375–379.PubMedGoogle Scholar
  441. 437.
    Yasuna ER. Hysterical amblyopia in children. Am J Dis Child. 1963;106:505.Google Scholar
  442. 437a.
    Xi Q, Li L, Traboulsi EI, et al. Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease. Mol Vis. 2009;15:638–645.PubMedGoogle Scholar
  443. 438.
    Yenice O, Onal S, Incili B, et al. Assessment of spatial-contrast function and short-wavelength sensitivity deficits in patients with migraine. Eye. 2007;21:218–223.PubMedGoogle Scholar
  444. 439.
    Younkin D. Topirate in the treatment of pediatric migraine. Headache. 2002;42:456. Abstract.Google Scholar
  445. 440.
    Zemen W, Donahue S, Dyken P, et al. The neuronal ceroid lipofuscinosis (Batten-Vogt syndrome). In: Vinken PJ, Bruyn GW, eds. Leukodystrophies and Polio Dystrophies. Handbook of Clinical Neurology, X. New York: American Elsevier; 1970:588–679.Google Scholar
  446. 441.
    Zenker G, Erbel R, Kramer G, et al. Transesophageal two-dimensional echocardiography in young patients with cerebral ischemic events. Stroke. 1988;19:345–348.PubMedGoogle Scholar
  447. 442.
    Zhang K, Bither PP, Park R, et al. A dominant Stargardt’s macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol. 1994;112:759–764.PubMedGoogle Scholar
  448. 443.
    Ziegler DK, Hurwitz A, Hassanein RS, et al. Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol. 1987;44:486–489.PubMedGoogle Scholar
  449. 444.
    Zung A, Margalith D. Ictal cortical blindness: a case report and review of the literature. Dev Med Child Neurol. 1993;35:917–926.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Michael C. Brodsky
    • 1
  1. 1.Professor of Ophthalmology and NeurologyMayo ClinicRochesterUSA

Personalised recommendations